# Safety and Efficacy of L-NAME and Midodrine to Increase MAP

> **NCT00835224** · PHASE2 · COMPLETED · sponsor: **US Department of Veterans Affairs** · enrollment: 34 (actual)

## Conditions studied

- Orthostatic Hypotension
- Spinal Cord Injury

## Interventions

- **DRUG:** L-NAME
- **DRUG:** Midodrine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00835224
- **Lead sponsor:** US Department of Veterans Affairs
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2013-06
- **Final completion:** 2013-08
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2014-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00835224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00835224, "Safety and Efficacy of L-NAME and Midodrine to Increase MAP". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00835224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*